Solution to a billion-dollar problem: MustGrow Biologics validates business model – Revolutionary news also for Bayer and Corteva Agriscience

The threat: When genetics alone is no longer enough

To understand the significance of MustGrow's news, one must take a look at the situation in the seed industry. Market leaders such as Corteva Agriscience and Bayer have invested billions in breeding resistant rapeseed varieties. These genetic "shields" have long been the standard. But nature adapts: as industry analyses show, more and more pathogenic variants of clubroot are breaking through these resistances.

The disease attacks the roots, preventing the plant from absorbing nutrients and causing it to die. As there are currently no effective registered products for suppressing clubroot, farmers face the threat of total crop failure. This is precisely where MustGrow comes into play. The Canadian company's biological solution does not repair genetics, but rather remediates the soil in a sustainable manner, making the fields ready again for the seeds of large corporations.

Breakthrough for MustGrow Biologics: Hard data from field trials

On Tuesday, MustGrow provided proof that their theory also works in the harsh reality of agriculture. In a two-year program covering around 40 hectares (100 acres) in the Canadian provinces, the TerraMG™ product was tested under real-world conditions. The results are spectacular for agriculture and provide the necessary validation for commercial adaptation.

The field trial series showed varying results depending on weather conditions. In the wet year of 2024, with higher disease pressure, TerraMG™ achieved yield increases of up to 7 bushels/acre – equivalent to a 19% yield improvement compared with the Canadian average of 36 bushels/acre. For the farmer, this represented an added value of CAD 91 per acre. In the drier year of 2025, with lower clubroot pressure, TerraMG™ showed increases of 1-2 bushels/acre. At the same time, the technology significantly reduced the visible symptoms of clubroot, such as the typical gall formation on the roots. Instead, it promoted the development of a robust, healthy root system. In the wet year of 2024, the concentration of clubroot spores also decreased by up to 95%. Particularly relevant for investors is the design of the field trial: the tests were not conducted in isolation in a laboratory, but on a large scale on agricultural land, which underscores the industrial relevance and scalability of the data.

TerraMG™ works with the power of mustard

The technological heart of MustGrow is as ingenious as it is natural. TerraMG™ is based on active ingredients extracted from the mustard plant. Rapeseed and mustard belong to the same plant family, but while rapeseed is susceptible, mustard has a natural defense mechanism against soil diseases. MustGrow has isolated this mechanism and turned it into a usable form. The product acts as a soil fumigant, killing harmful pathogens and nematodes without leaving behind the negative ecological consequences of synthetic chemicals. For investors, this is the key point: MustGrow provides a solution that fits seamlessly into existing agricultural processes, solving a major problem for farmers and seed producers.

MustGrow as an ecological problem solver for the agricultural industry

The new findings from the field trial are a game-changer. Until now, MustGrow was a promising research company – with the completion of the test run under real conditions on 40 hectares, proof of concept on a commercial scale has been provided. For the canola industry, which contributes nearly $30 billion annually to the Canadian economy, according to the Canola Council of Canada, TerraMG™ is a boon. While Bayer and Corteva continue to provide excellent seeds developed for maximum yield, MustGrow offers the necessary soil protection to allow these seeds to reach their full potential.

With a yield increase of over 19% in the wet year of 2024, MustGrow provides exactly the argument that convinces farmers and seed producers such as Bayer, with whom MustGrow already cooperates. With its latest field trial, the company has secured a promising starting position in one of the world's most important agricultural markets. MustGrow's stock has recently broken out of its sideways trend and is showing momentum. It appears that the stock could soon reach new heights. The company has already taken an important first operational step in this direction with its latest findings. It is currently working on getting its product approved by the Canadian health authorities.